Gut microbiome: a key player in cancer immunotherapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The impact of microbiome in urological diseases: a systematic review.International urology and nephrology · 2019
   Pooled it
2. Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma.Oncoimmunology · 2026
   Review
3. Microbiome modulation of tumorigenesis and immune responses.Journal of biomedical science · 2026
   Review
4. The role of intestinal flora on tumor immunotherapy: recent progress and treatment implications.Heliyon · 2024
   Review
5. Potential predictors of immunotherapy in small cell lung cancer.Pathology oncology research : POR · 2023
   Review
6. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.International journal of molecular sciences · 2022
   Review
7. Breath methane to hydrogen ratio as a surrogate marker of intestinal dysbiosis in head and neck cancer.Scientific reports · 2020
   Article
8. Intestinal microbiota: a new force in cancer immunotherapy.Cell communication and signaling : CCS · 2020
   Review
9. Is obesity a disease?-the evolving concepts, cancer paradox and association with improved cancer immunotherapy efficacy.Hepatobiliary surgery and nutrition · 2020
   Article
10. Potential factors of specialists' willingness to write editorial and commentary: a retrospective study based on 5,091 invitations.Annals of translational medicine · 2019
    Article

Corrections and comments

• Comment on
  Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.